A case of atypical McCune-Albright syndrome requiring optic nerve decompression

Annals of Plastic Surgery

Volumn 43, Issue 4, 1999, Pages 430-435

  Yavuzer, Reha ^a   Khilnani, Rubi ^a   Jackson, Ian T ^a   Audet, Biaise ^a  

^a Third Floor Fisher Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ALBRIGHT SYNDROME; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GIGANTISM; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; MALE; NERVE DECOMPRESSION; OPTIC NERVE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; THYROID DISEASE; VISUAL FIELD DEFECT;

ADOLESCENT; DECOMPRESSION, SURGICAL; FIBROUS DYSPLASIA, POLYOSTOTIC; HUMANS; MALE; NERVE COMPRESSION SYNDROMES; OPTIC NERVE INJURIES;

EID: 0032876549     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-199910000-00015     Document Type: Article

References (52)

1. Albright F, Butler AM, Hampton AO, et al. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases. N Engl J Med 1937;216:727-746
2. McCune DJ. Osteitis fibrosa cystica: the case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 1936;52:743-747
3. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome. Long-term follow-up. JAMA 1986;256:2980-2984
4. Schwindinger WF, Levine MA. McCune-Albright syndrome. Trend Endocrinol Metab 1993;7:238-242
5. Zangeneh F, Lulejian GA, Steiner MM. McCune-Albright syndrome with hyperthyroidism. Am J Dis Child 1966; 111:644-648
6. Misaki M, Shima T, Ikoma J, et al. Acromegaly and hyperthyroidism associated with McCune-Albright syndrome. Horm Res 1988;30:26-27
7. Ehrig U, Wilson DR. Fibrous dysplasia of bone and primary hyperparathyroidism. Ann Intern Med 1972;77:234-238
8. Danon M, Robboy SJ, Kim S, et al. Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy. J Pediatr 1975;87:917-921
9. Benjamin DR, McRoberts JW. Polyostotic fibrous dysplasia associated with Cushing syndrome: case report with autopsy findings. Arch Pathol 1973;96:176-178
10. Kupcha PC, Guille JT, Tassanawipas A, et al. Polyostotic fibrous dysplasia and acromegaly. J Pediatr Orthop 1991; 11:95-99
11. Pacini F, Perri G, Bagnolesi P, et al. McCune-Albright syndrome with gigantism and hyperprolactinemia. J Endocrinol Invest 1987;10;417-420
12. Carr D, Mathie IK, Manners AR, et al. Hyperprolactinameia in a patient with McCune-Albright syndrome. Br J Obstet Gynaecol 1979;86:330-331
13. Chung KF, Alaghband-Zadeh J, Guz A. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Am J Dis Child 1983;137:134-136
14. Joishy SK, Morrow LB. McCune-Albright syndrome associated with a functioning pituitary chromophobe adenoma. J Pediatr 1976;89:73-75
15. Cremonini N, Graziano E, Chiarini V, et al. Atypical McCune-Albright syndrome associated with growth hormone-prolactin secreting pituitary adenoma: natural history, long term follow-up, and SMS 201-995-bromocriptine combined treatment results. J Clin Endocrinol Metab 1992;75:1166-1169
16. Hamilton Jr CR, Maloof F. Unusual types of hyperthyroidism. Medicine (Baltimore) 1976;52:195-215
17. Vukovic D, Katanic D, Parric V, et al. The McCune-Albright syndrome with hyperthyroidism, acromegaly and hypophosphatemic-hyperphosphaturic rickets. Med Pregl 1990;43:301-304
18. McArthur RG, Hales AB, Lamberg PW. Albright syndrome with rickets. Mayo Clin Proc 1979;54:313-320
19. Shires R, Whyte M, Avioli LV. Idiopathic hypothalamic hypogonadotropic hypogonadism with polyostotic fibrous dysplasia. Arch Intern Med 1979;139:1187-1189
20. Weinstein LS, Shenker A, Gejman PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325:1688-1695
21. Shenker A, Weinstein LS, Moran A, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein Gs. J Pediatr 1993;123:509-518
22. Marie PJ, dePollak C, Chanson P, et al. Increased proliferation of osteoblastic cells expressing the activating Gsα mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 1997;150:1059-1069
23. Riminucci M, Fisher LW, Shenker A, et al. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 1997;151:1587-1600
24. Feuillan PP. McCune-Albright syndrome. Curr Ther Endocrinol Metab 1997;6:235-239
25. Edgerton MT, Persing JA, Jane JA. The surgical treatment of fibrous dysplasia. Ann Surg 1985;202:459-479
26. Hall MB, Scalar AG, Gardner DF. Albright's syndrome with reactivation of fibrous dysplasia secondary to pituitary adenoma and further complicated by osteogenic sarcoma. Oral Surg 1984;57:616-619
27. Nager GT, Kennedy DW, Kopstein E. Fibrous dysplasia: a rview of the disease and its manifestations in the temporal bone. Ann Otol Rhinol Laryngol 1982;92:1-52
28. Espinosa JM, Elizalde A, Aquerreta JD, et al. Fibrous dysplasia of the maxilla. Ann Otol Rhinol Laryngol 1998; 107:175-177
29. Schwartz DT, Alpert M. The malignant transformation of fibrous dysplasia. Am J Med Sci 1964;247:1
30. Reddy KTV, Vinayak BC, Jefferis AF, et al. Fibrous dysplasia of the temporal bone. Ann Otol Rhinol Laryngol 1994;103:74-76
31. Moore AT, Buncic JR, Munro IR. Fibrous dysplasia of the orbit in childhood. Clinical features and management. Ophthalmology 1985;92:12-20
32. Fries JW. The roentgen features of fibrous dysplasia. AJR Am J Roentgenol 1957;77:71-88
33. Chanson P, Dib A, Visot A, et al. McCune-Albright syndrome and acromegaly: clinical studies and responses to treatment in five cases. Eur J Endocrinol 1994;131:229-234
34. Szwajkun P, Chen Y, Yeow VKL, et al. The "Taiwanese giant": hormonal and genetic influences in fibrous dysplasia. Ann Plast Surg 1998;41:75-80
35. Present D, Bertoni F, Enneking WF. Osteosarcoma of the mandible arising in fibrous dysplasia. Clin Orthop Rel Res 1986;204:238-244
36. Mortensen A, Bojsen-Moller M, Ramussen P. Fibrous dysplasia of the skull with acromegaly and sarcomatous transformation. J Neurooncol 1989;7:25-29
37. Gaiddon C, Boutillier AL, Monnier D, et al. Genomic effects of the putative oncogene Gsα. Chronic transcriptional activation of the c-fos protooncogene in endocrine cells. J Biol Chem 1994;269:22663-22671
38. Gaiddon C, Tian J, Loeffler JP, et al. Constitutively active Gsa subunits stimulate Pit-1 promoter activity via a protein kinase A-mediated pathway acting through deoxyribonucleic acid binding sites both for Pit-1 and for adenosine 3′,5′-monophosphate response element-binding protein. Endocrinology 1996;137:1286-1291
39. Machwate M, Jullienne A, Moukhtar M, et al. Temporal variation of c-fos proto-oncogene expression during osteoblast differentiation and osteogenesis in developing rat bone. J Cell Biochem 1995;57:62-70
40. Machwate M, Jullienne A, Moukhtar M, et al. c-fos Protooncogene is involved in the mitogenic effect of transforming growth factor-β in osteoblastic cells. Mol Endocrinol 1995;9:187-198
41. Candeliere GA, Glorieux FH, Prud'homme J, et al. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 1995; 332:1546-1551
42. Liens D, Delmas PD, Meunier P. Long term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 1994;343:953-954
43. Geffner ME, Nagel RA, Dietrich RB, et al. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. J Pediatr 1987;111:740-743
44. Premawardhana LDKE, Vora JP, Mills R, et al. Acromegaly and its treatment in the McCune-Albright syndrome. Clin Endocrinol 1992;36:605-608
45. Jackson IT, Hide TAH, Gomuwka PK, et al. Treatment of cranio-orbital fibrous dysplasia. J Maxillofac Surg 1982; 10:138-141
46. Chen YR, Noordhoff MS. Treatment of craniomaxillofacial fibrous dysplasia: how early and how extensive? Plast Reconstr Surg 1990;86:835-842
47. Seiff S. Optic nerve decompression in fibrous dysplasia: indications, efficacy, and safety. Plast Reconstr Surg 1997; 100:1611-1612 [Letter]
48. Munro IR. Discussion: Treatment of craniomaxillofacial fibrous dysplasia: how early and how extensive. Plast Reconstr Surg 1991;86:799-800
49. Kurimoto M, Endo S, Onizuka K, et al. Extradural optic nerve decompression for fibrous dysplasia with a favorable visual outcome. Neurol Med Chir (Tokyo) 1996;36:102-105
50. Saito K, Suzuki Y, Nehashi K, et al. Unilateral extradural approach for bilateral optic canal release in a patient with fibrous dysplasia. Surg Neurol 1990;34:124-128
51. Weisman JS, Hepler RS, Vinters HV. Reversible visual loss caused by fibrous dysplasia. Am J Ophthalmol 1990;110: 244-249
52. Lauritzen C, Alberius P, Santanelli F, et al. Repositioning of craniofacial tumorous bone after autoclaving. Scand J Plast Reconstr Surg Hand Surg 1991;25:161-165